Intranasal and subcutaneous immunization under the effect of estradiol leads to better protection against genital HSV-2 challenge compared to progesterone

被引:38
作者
Bhavanam, Sudha [1 ]
Snider, Denis R. [2 ]
Kaushic, Charu [1 ]
机构
[1] McMaster Univ, Michael G DeGroote Ctr Learning & Discovery, Ctr Gene Therapeut, Dept Pathol & Mol Med, Hamilton, ON, Canada
[2] McMaster Univ, Intestinal Dis Res Program, Dept Pathol & Mol Med, Hamilton, ON, Canada
基金
加拿大健康研究院;
关键词
Sex hormone; Immunization; HSV-2; Protection; Estradiol; Immune responses;
D O I
10.1016/j.vaccine.2008.08.045
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This Study examined the effect of hormonal environment on intranasal and Subcutaneous routes of immunization in a genital herpes infection model. Ovariectomized mice were treated with estradiol (E-2), progesterone (P-4) or placebo hormone pellets and immunized intranasally (i.n.) or subcutaneously (s.c.) with attenuated HSV-2. Immunized mice were subsequently challenged, intravaginally, with wild-type HSV-2. Mice immunized under the influence of E-2 showed higher Survival rates, reduced pathology and significantly lower viral shedding compared with those immunized under the influence Of P4 or placebo, by both i.n. and s.c. routes. Vaginal and serum anti-HSV-2 IgG, but not IgA, levels correlated with decreased E-2-treated, i.n. immunized mice. We conclude that immunization Linder the influence of E-2 afforded better protection compared to placebo and P-4, by both routes of immunization. Female sex hormones can influence immune responses and outcome of viral challenge in the genital tract following systemic immunization. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6165 / 6172
页数:8
相关论文
共 31 条
[2]   Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection - Two randomized controlled trials [J].
Corey, L ;
Langenberg, AGM ;
Ashley, R ;
Sekulovich, RE ;
Izu, AE ;
Douglas, JM ;
Handsfield, HH ;
Warren, T ;
Marr, L ;
Tyring, S ;
DiCarlo, R ;
Adimora, AA ;
Leone, P ;
Dekker, CL ;
Burke, RL ;
Leong, WP ;
Straus, SE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (04) :331-340
[3]  
COREY L, 1999, SEXUALLY TRANSMITTED, P285
[4]   ANTI-GLYCOPROTEIN-B MONOCLONAL-ANTIBODY PROTECTS T-CELL-DEPLETED MICE AGAINST HERPES-SIMPLEX VIRUS-INFECTION BY INHIBITION OF VIRUS-REPLICATION AT THE INOCULATED MUCOUS-MEMBRANES [J].
EISHUBINGER, AM ;
SCHMIDT, DS ;
SCHNEWEIS, KE .
JOURNAL OF GENERAL VIROLOGY, 1993, 74 :379-385
[5]   Effects of reproductive hormones on experimental vaginal candidiasis [J].
Fidel, PL ;
Cutright, J ;
Steele, C .
INFECTION AND IMMUNITY, 2000, 68 (02) :651-657
[6]   Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract [J].
Gallichan, WS ;
Rosenthal, KL .
VIROLOGY, 1996, 224 (02) :487-497
[7]   Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization [J].
Gallichan, WS ;
Rosenthal, KL .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (05) :1155-1161
[8]   SPECIFIC SECRETORY IMMUNE-RESPONSES IN THE FEMALE GENITAL-TRACT FOLLOWING INTRANASAL IMMUNIZATION WITH A RECOMBINANT ADENOVIRUS EXPRESSING GLYCOPROTEIN-B OF HERPES-SIMPLEX VIRUS [J].
GALLICHAN, WS ;
ROSENTHAL, KL .
VACCINE, 1995, 13 (16) :1589-1595
[9]   Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract [J].
Gallichan, WS ;
Woolstencroft, RN ;
Guarasci, T ;
McCluskie, MJ ;
Davis, HL ;
Rosenthal, KL .
JOURNAL OF IMMUNOLOGY, 2001, 166 (05) :3451-3457
[10]   Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue [J].
Gillgrass, AE ;
Tang, VA ;
Towarnicki, KM ;
Rosenthal, KL ;
Kaushic, C .
JOURNAL OF VIROLOGY, 2005, 79 (05) :3117-3126